14-24256011-T-C
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM2PM5PP3_StrongPP5
The ENST00000206765.11(TGM1):āc.1469A>Gā(p.Asp490Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000575 in 1,566,280 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D490N) has been classified as Pathogenic.
Frequency
Consequence
ENST00000206765.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TGM1 | NM_000359.3 | c.1469A>G | p.Asp490Gly | missense_variant | 10/15 | ENST00000206765.11 | NP_000350.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGM1 | ENST00000206765.11 | c.1469A>G | p.Asp490Gly | missense_variant | 10/15 | 1 | NM_000359.3 | ENSP00000206765 | P1 | |
TGM1 | ENST00000544573.5 | c.143A>G | p.Asp48Gly | missense_variant | 4/9 | 2 | ENSP00000439446 | |||
TGM1 | ENST00000559136.1 | c.542A>G | p.Asp181Gly | missense_variant | 6/7 | 5 | ENSP00000453337 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152106Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000613 AC: 11AN: 179310Hom.: 0 AF XY: 0.000105 AC XY: 10AN XY: 95220
GnomAD4 exome AF: 0.0000594 AC: 84AN: 1414174Hom.: 1 Cov.: 31 AF XY: 0.0000859 AC XY: 60AN XY: 698700
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152106Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74304
ClinVar
Submissions by phenotype
Autosomal recessive congenital ichthyosis 1 Pathogenic:3Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Jun 21, 2017 | - - |
Likely pathogenic, criteria provided, single submitter | curation | Laboratory of Medical Genetics, National & Kapodistrian University of Athens | Feb 01, 2024 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jun 12, 2023 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 01, 2003 | - - |
Lamellar ichthyosis Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 03, 2023 | Variant summary: TGM1 c.1469A>G (p.Asp490Gly) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 6.1e-05 in 179310 control chromosomes (gnomAD). This frequency is not higher than the estimated maximum expected for a pathogenic variant in TGM1 causing Lamellar Ichthyosis (6.1e-05 vs 0.0021), allowing no conclusion about variant significance. c.1469A>G has been reported in the literature in two compound heterozygous siblings affected with self-healing collodion baby (SHCB), which is a milder condition related to Lamellar Ichthyosis (Raghunath_2003), where both patients carried a (likely) pathogenic variant in trans. This publication also reported experimental evidence evaluating an impact on protein function, and demonstrated reduced TGase I activity under elevated hydrostatic pressure (Raghunath_2003). Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after, and classified the variant as pathogenic (n=1), and uncertain significance (n=1). Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 03, 2023 | This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 490 of the TGM1 protein (p.Asp490Gly). This variant is present in population databases (rs121918724, gnomAD 0.03%). This missense change has been observed in individual(s) with spontaneous healing of congenital ichthyosis (PMID: 12542526). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 12491). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TGM1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects TGM1 function (PMID: 12542526). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at